KEY DEADLINES
Abstract Submission Deadline: CLOSED
Early Bird Registration Deadline: CLOSED
Accommodation Deadline: CLOSED
Standard Registration Deadline: CLOSED
POSTER LISTING
The committee are pleased to announce the poster listing is now available. This will continue to be updated as more details are confirmed, please note this is subject to change without notice.
Clinical Management and Therapeutics
1.Retreatment of persistent COVID-19 in immunocompromised patients: a clinical case series
Isabella Atlas, Sir Charles Gairdner Hospital, WA, Australia
2.GP proactive engagement: reaching the vaccine-fatigued
Christine Ferlazzo, North Western Melbourne Primary Health Network, VIC, Australia
3.Extended Monitoring of Immunosuppressed COVID 19 (Omicron variant) Patients for Late Respiratory Deterioration: Is This Required?
Christina Hannah, Royal Brisbane And Women’s Hospital, QLD, Australia
Designing resources for people with long COVID
Letisha Hatte, Lung Foundation Australia
4.Induction of antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggests imprinting to the ancestral strain of SARS-CoV-2
Siddhartha Mahanty, The University of Melbourne, VIC, Australia
5.Clinical and Demographic predictors of COVID-19 severity in a highly vaccinated population: a multicenter cross-sectional study in Aotearoa New Zealand, 2022
Michael Maze, University of Otago, Christchurch, New Zealand
7.Predicting the efficacy of passive antibody treatment of COVID-19
Eva Maria Stadler, The Kirby Institute, NSW, Australia
Discovery and Translational Science, Biology, Pathogenesis and Transmission
11.Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 & influenza A/B rapid antigen tests
Mitchell Batty, The Peter Doherty Institute, VIC, Australia
12.Impact of COVID-19 vaccination on long COVID: a systematic review
Oyuka Byambasuren, Bond University, QLD, Australia
13.Impacts of Long COVID on Physical Performance in People with Intellectual Disabilities
Chi Chung CHENG, Tung Wah College, Hong Kong
14.Immune-Viral Dynamics Modeling of the Basis for Individual Variation in COVID-19
Andrea Govender, MSD, NSW, Australia
15.Expansion of ancestral strain-specific AIM positive CD4 cell subpopulations in vaccinated individuals with breakthrough infections with SARS-CoV-2 variants
Siddhartha Mahanty, The University of Melbourne, VIC, Australia
16.IMPAIRED TRANSIENT RECEPTOR POTENTIAL MELASTATIN 3 IN POST COVID-19 CONDITION AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME PATIENTS
Etianne Martini Sasso, Griffith University, QLD, Australia
17.Respiratory viral detection and whole-genome sequencing from COVID-19 rapid antigen test devices
George Taiaroa, University of Melbourne, VIC, Australia
18.Development and characterisation of a SARS-CoV-2 RNA vaccine expressing three linked-RBD domains
Yadana Zaw, University Of Melbourne, VIC, Australia
Prevention, Epidemiology and Public Health Interventions
19.Teledentistry utilization as examination method during the COVID-19 pandemic: Findings from randomized controlled trial
Khalid Aboalshamat, Umm Al-qura University, Makkah, Saudi Arabia
20.QoVAX Program: Queensland statewide digitally-integrated biobank and linked data repository to track COVID-19 vaccine and health outcomes
Janet Davies, Metro North Health, QLD, Australia
21.Humoral immune responses to ancestral SARS-CoV-2 wild type and variant strains following COVID-19 vaccination in people with HIV
David Griffin, Alfred Health, VIC, Australia
22.Assessment of Baguio City, Philippines Policy Responses to Public Health Concerns during the early on – set of the COVID-19 Pandemic
Rosemary Gutierrez, University of The Philippines Baguio, Benguet Province, Philippines
COVID-19: Experiences of people with a lung disease
Letisha Hatte, Lung Foundation Australia
23.Quantifying the impact of different public health and social measures on population mixing vis-à-vis contact matrices in Hong Kong
Sze Man Kathy Leung, The University of Hong Kong, Hong Kong
24.Assessment of the training framework for the Aboriginal and Torres Strait Islander Respiratory Infection POCT Program
Polina Mazonka, Flinders University International Centre For Point-of-care Testing, SA, Australia
25.Survival analysis and risk factors in COVID-19 patients in Victoria
Joselin Mckittrick, Department of Health Victoria, VIC, Australia
27.COVID-19 Recovery Lessons Learned
Karen Slater, Metro South Public Health Unit, QLD, Australia
28.ONSITE SCHOOLING AND SARS-COV-2 EPIDEMIOLOGY
Darren Suryawijaya Ong, Murdoch Children’s Research Institute, VIC, Australia
29.Reported Pregnancy Outcomes Across NVX-CoV2373 COVID-19 Vaccine Primary Series and Booster Dose Clinical Studies
Seth Toback, Novavax Inc., Maryland, United States
30.Queensland Vaccine Safety and Efficacy Program (QoVAX) Statewide Study
Selina Ward, Queensland Health, QLD, Australia
31.HEALTH CARE ACCESS AND USE BEFORE AND AFTER THE COVID-19 PANDEMIC
Yanqin Zhang, Burnet Institute, VIC, Australia
Social, Political and Cultural Aspects
32.Understanding COVID-19 ‘infodemics’: An analysis of user-generated online information about public health interventions during a SARS-CoV-2 outbreak in Vietnam, July – September 2020
Ha-Linh Quach, Duke-nus Medical School, Singapore
33.Health care provider perceptions of current and future uptake of COVID-19 vaccines in Europe and North America
Seth Toback, Novavax Inc., Maryland, United States